Dronabinol has preferential antileukemic activity in acute lymphoblastic and myeloid leukemia with lymphoid differentiation patterns

Kerstin Maria Kampa-Schittenhelm(University Children's Hospital Tübingen), Marcus M. Schittenhelm(University Children's Hospital Tübingen)

BMC Cancer

January 16, 2016

10.1186/s12885-015-2029-8

Cited by 33

Related Papers

Quizartinib (AC220) is a potent second generation class III tyrosine kinase inhibitor that displays a distinct inhibition profile against mutant-FLT3, -PDGFRA and -KIT isoforms

|Molecular Cancer|2013|121